• slider
    International Conference on
    ONCOLOGY AND RADIOLOGY
    October 27-29, 2016, Dubai, UAE
  • slider
    International Conference on
    ONCOLOGY AND RADIOLOGY
    October 27-29, 2016, Dubai, UAE
  • slider

Theme: Cancer Free World - Possible or Not


      • Captivate with over 120+ high-level scientific speakers for a fresh industry perspective
      • Interactive plenary sessions with our best speakers
      • Learn from leading non-profit organizations and government bodies
      • Benefit from numerous extended networking opportunities that bring together all 500+ congress attendees regardless of where you spent your time over the 3 days. It is your best chance of the year to meet and network with hundreds of decision makers and like-minded peers.
      • The radiation oncology market is growing globally due to a number of factors centered around the aging of the population and the benefits accrued from new technology.
      • The market for radiotherapy was estimated at $5.8 billion in 2014 and is anticipated to increase at a compound annual growth rate (CAGR) of 6.7% to $8 billion by 2019.
      • The number of new cancer cases diagnosed annually is projected to increase from 14.9 million in 2015 to 20 million by 2025.The increase in new cases is due to a steadily aging population. Both developed and developing countries have aging populations.


       

      • Meet others in your field- can lead to new opportunities for collaborative efforts
      • New Tips & Tactics
      • Present your latest research
      • Learn from internationally renowned researchers including these invited speakers
      • Understand the current state of research and the challenges to future discovery
      • Meet with international colleagues, make new friends
      • Radiology Oncology surgical robot device markets at $4 billion in 2015 are anticipated to reach $7.3 billion by 2022 as next generation devices, systems, and instruments are introduced to manage cancer surgery through radiation excision that eliminates open cutting in the body.
      • According to a report from MEDraysintell, the global market for brachytherapy reached $705 million in 2015 and is expected to reach $2 billion in 2030, growing by 8 percent annually, mainly driven by the microspheres market as well as electronic brachytherapy.
         

ABOUT CONFERENCE

Magnus Group Conferences welcomes you to participate in the (ICOR 2016) International Conference on Oncology and Radiology at Dubai, UAE during October 27–29, 2016. Meet leading Registered nurses, Healthcare specialists, Deans, Doctors, Honory presidents, Professors, Society members, Association members from USA, Europe, Asia Pacific and Middle East at Emerging Magnus Group Cancer Conferences (cancer conferences) and Health Care Conferences.

The (ICOR 2016) International Conference on Oncology and Radiology will bring together a collection of investigators who are at the forefront of their field, and will provide opportunities for junior scientists and graduate students to interactively present their work and exchange ideas with established senior scientists. At Congress, you'll learn the latest developments in oncology and radiology in sessions led by renowned scientists across the globe. Plus, you'll have the opportunity to connect with more than 500 of your peers and celebrate your profession. You'll leave better educated and more invigorated than you thought possible. We wish to see you in 'Dubai' a capital city of United Arab Emirates, and a promising place to discover novel things in the field of science and technology.
Session Themes:

Cancer Treating Drugs Industry and Market

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the ovarian cancer drug market will more than triple over the next decade, increasing from $460 million in 2011 to $1.4 billion in 2021 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Market growth will be primarily driven by the penetration of new therapies into several market segments. The, which utilizes Decision Resources' proprietary suite of epidemiological cancer models that include the modeling of recurrent cases of ovarian cancer, finds that based on historical trends in recurrence risk as well as an increasing percentage of early-stage patients receiving drug treatment the number of drug-treated early-stage cases that develop recurrent advanced disease will decrease by around 3 percent per year through 2031.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Cancer Clinical Trials and drug development

 

Clinical trials are the way to make progress in preventing and treating cancer. Clinical trials must be done before new drugs are approved by U.S. Food and Drug Administration (FDA). They also must be done before new surgical or radiation therapy methods are regularly included with cancer treatment. People with cancer are often offered the option of treatment in a clinical trial. In a clinical trial, patients can be assured of receiving excellent treatment with the possibility of receiving additional new treatments that could help them. Their participation also helps contribute to improved treatments for future patients. Doctors generally do clinical research in three distinct phases: Phase I, Phase II and Phase III.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Organ Specific Cancer

Although emissions from petrochemical industries have been recognized as a cause of an increased in cancer deaths, its contribution to specific organ cancer incidence has not been investigated in a cohort study with an adequate sample size.Targeting cancer metabolism has the potential to lead to major advances in tumor therapy. Numerous promising metabolic drug targets have been identified. Yet, it has emerged that there is no singular metabolism that defines the oncogenic state of the cell. Rather, the metabolism of cancer cells is a function of the requirements of a tumor. Hence, the tissue of origin, the (epi) genetic drivers, the aberrant signaling, and the microenvironment all together define these metabolic requirements. In this chapter we discuss in light of (epi)genetic, signaling, and environmental factors the diversity in cancer metabolism based on triple-negative and estrogen receptor-positive breast cancer, early- and late-stage prostate cancer, and liver cancer. These types of cancer all display distinct and partially opposing metabolic behaviors. Yet, for each of the cancers, their distinct metabolism supports the oncogenic phenotype. Finally, we will assess the therapeutic potential of metabolism based on the concepts of metabolic normalization and metabolic depletion.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Cancer Nanotechnology

The use of nanotechnology in cancer treatment offers some exciting possibilities, including the possibility of destroying cancer tumors with minimal damage to healthy tissue and organs, as well as the detection and elimination of cancer cells before they form tumors.Most efforts to improve cancer treatment through nanotechnology are at the research or development stage. However the effort to make these treatments a reality is highly focused. For example, The Alliance for Nanotechnology in Cancer, established by the U.S. National Cancer Institute, is fostering innovation and collaboration among researchers to resolve some of the major challenges in the application of nanotechnology to cancer. In addition, there are many universities and companies' worldwide working in this area. It is possible that these efforts will result in cancer becoming being nearly eliminated in a decade or so, in the same way that vaccines nearly eliminated smallpox in the last century.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Non-Small Cell Lung Cancer

Lung cancer starts when cells in the lung become abnormal and begin to grow out of control. As more cancer cells develop, they can form into a tumor and spread to other areas of the body. (To learn more about how cancers start and spread. Types of non-small cell lung cancer. There are 2 main types of lung cancer: About 85% to 90% of lung cancers are non-small cell lung cancer (NSCLC) & About 10% to 15% are small cell lung cancer (SCLC). Squamous cell (epidermoid) carcinoma: About 25% to 30% of all lung cancers are squamous cell carcinomas. These cancers start in early versions of squamous cells, which are flat cells that line the inside of the airways in the lungs. They are often linked to a history of smoking and tend to be found in the central part of the lungs, near the main airway (bronchus). Large cell (undifferentiated) carcinoma: This type accounts for about 10% to 15% of lung cancers. It can appear in any part of the lung. It tends to grow and spread quickly, which can make it harder to treat. A subtype of large cell carcinoma, known as large cell neuroendocrine carcinoma, is fast-growing cancer that is very similar to small cell lung cancer.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Metastatic cancer cells

Metastasis, or metastatic disease, is the spread of cancer or another disease from one organ or part to another not directly connected with it. The new occurrences of disease thus generated are referred to as metastases. Metastasis is a Greek word meaning "displacement", from meta, "next", and stasis, "placement". Cancer occurs after a single cell in a tissue is progressively genetically damaged to produce cells with uncontrolled proliferation. This uncontrolled proliferation by mitosis produces a primary heterogeneous tumor. The cells which constitute the tumor eventually undergo metaplasia, followed by dysplasia then anaplasia, resulting in a malignant phenotype. This malignancy allows for invasion into the circulation, followed by invasion to a second site for tumorigenesis. Some cancer cells acquire the ability to penetrate the walls of lymphatic and/or blood vessels, after which they are able to circulate through the bloodstream (circulating tumor cells) to other sites and tissues in the body. This process is known (respectively) as a lymphatic or hematogenous spread.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Molecular cancer biomarkers

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum. In many areas of medicine, biomarkers are limited to proteins identifiable or measurable in the blood or urine. However, the term is often used to cover any molecular, biochemical, physiological, or anatomical property that can be quantified or measured.The National Cancer Institute (NCI), in particular, defines biomarker as a: "A biological molecule found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule."

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Therapeutic vaccines for cancer

A cancer vaccine is a vaccine that either treats existing cancer or prevents the development of cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. There are currently no vaccines able to prevent all cancers, however, vaccines against some oncoviruses have proven extremely effective. Some types of cancer, such as cervical cancer and some liver cancers, are caused by viruses (oncoviruses), and traditional vaccines against those viruses, such as HPV vaccine and hepatitis B vaccine, will prevent those types of cancer. These anti-viral vaccines are not further discussed in the rest of this article. Other cancers are to some extent caused by bacterial infections (e.g. stomach cancer and Helicobacter pylori) and traditional vaccines against cancer-causing bacteria are also not discussed in this article .Scientists are continuing research and development of vaccines against other types of cancer. Some researchers believe that cancer cells routinely arise and are destroyed by the healthy immune system and that cancer forms when the immune system fails to destroy them.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Colorectal Cancer Symptoms and Stages

Colorectal cancer also known as colon cancer, rectal cancer, or bowel cancer is the development of cancer in the colon or rectum (parts of the large intestine). It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time. Risk factors for colorectal cancer include lifestyle, older age, and inherited genetic disorders. Other risk factors include diet, smoking, alcohol, lack of physical activity, family history of colon cancer and colon polyps, the presence of colon polyps, race, exposure to radiation, and even other diseases such as diabetes and obesity. Genetic disorders only occur in a small fraction of the population. A diet high in red, processed meat, while low in fiber increases the risk of colorectal cancer. Other diseases such as inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, can increase the risk of colorectal cancer.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Cancer types and their treatment

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Not all tumors are cancerous; benign tumors do not spread to other parts of the body. Possible signs and symptoms include a new lump, abnormal bleeding, a prolonged cough, unexplained weight loss, and a change in bowel movements among others. While these symptoms may indicate cancer, they may also occur due to other issues. There are over 200 different known cancers that affect humans. Tobacco use is the cause of about 22% of cancer deaths. Another 10% is due to obesity, a poor diet, lack of physical activity, and consumption of alcohol. Other factors include certain infections, exposure to ionizing radiation, and environmental pollutants. In the developing world, nearly 20% of cancers are due to infections such as hepatitis B, hepatitis C, and human papillomavirus (HPV). It is then typically further investigated by medical imaging and confirmed by biopsy.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Women cancer diagnostics

As a woman, your lifetime risk for all cancers combined is now one in three. Cancer ranks as the second most frequent cause of death for U.S. women, after heart disease. According to the American Cancer Society, in 2014, an estimated 810,000 American women will be diagnosed with cancer, and about 275,000 women will die of some form of the disease. Yet a recent survey found that only about 50 percent of women discussed the pros of cancer screening with their doctors before making a screening decision - still far more than the 15 percent who talked to their doctors about the cons of screening. Breast cancer is the most frequently diagnosed cancer in U.S. women, excluding cancers of the skin. If the current rate stays the same, women born today have about a 1 in 8 chance of developing breast cancer at some point during their lives.1 Although mortality rates have steadily decreased over the past decades, breast cancer remains the second leading cause of cancer deaths in U.S. women, exceeded only by lung cancer.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Surgical oncology

Surgical oncology is the branch of surgery applied to oncology; it focuses on the surgical management of tumors, especially cancerous tumors. As one of the several modalities in the management of cancer, the specialty of surgical oncology, before modern medicine the only cancer treatment with a chance of success, has evolved in steps similar to medical oncology (pharmacotherapy for cancer), which grew out of hematology, and radiation oncology, which grew out of radiology. The Ewing Society known today as the Society of Surgical Oncology was started by surgeons interested in promoting the field of oncology. Though it has not been ratified by a specialty Board certification, the area of expertise is coming to its own by the success of combined treatment with chemotherapy, radiotherapy, and targeted biologic treatments. The proliferation of cancer centers will continue to popularize the field, as will developments in minimally invasive techniques, palliative surgery, and neo-adjuvant treatments.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Gynecologic oncology

Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers. In the United States, 82,000 women have diagnosed with gynecologic cancer annually. In 2013, an estimated 91,730 were diagnosed. The Society of Gynecologic Oncology and the European Society of Gynecological Oncology are professional organizations for gynecologic oncologists, and the Gynecologic Oncology Group is a professional organization for gynecological oncologists as well as other medical professionals who deal with gynecologic cancers. The Foundation for Women's Cancer is the major U.S. organization that raises awareness and research funding and provides educational programs and materials about gynecologic cancers.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Comprehensive Geriatric Oncology

Geriatric oncology is a branch of medicine that is concerned with the diagnosis and treatment of cancer in the elderly, usually defined as aged 65 and older. This fairly young but increasingly important subspecialty incorporates the special needs of the elderly into the treatment of cancer. In the last few years; this particular subspecialty has received a lot of attention. A large proportion of the populations of developed countries is aging. In the United States, 20% of the population will be older than 65 years of age by the year 2030. Those 85 years and older will be the most rapidly growing group. This is compounded by the fact that the majority of cancer patients will be in this age group. Age in itself is one of the most important risk factors for developing cancer. Currently, 60% of newly diagnosed malignant tumors and 70% of cancer deaths occur in people aged 65 years or older. Many cancers are linked to aging; these include breast, colorectal, prostate, pancreatic, lung, bladder and stomach cancers.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Oncology Nursing Care

Oncology nursing education has focused on the knowledge and practice of providing care to cancer patients. In-service education or certificate courses at a community college level over and above that acquired in basic nursing education may deliver the knowledge. Cancer organizations have focused attention on developing nurses to administer chemotherapy, work in clinical trials, deliver care to patients receiving radiation treatment, and acquire specialized skills (e.g. central line management). Some organizations have developed formal educational processes to support nurses in working with cancer patients within major tertiary centers and in communities. Analysis of the current situation reveals the role that continuing education has played in supporting oncology practice, but there are significant limitations in the breadth of role preparation and programs in oncology nursing.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Breast cancer

Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, or a red scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin. Risk factors for developing breast cancer include female sex, obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionizing radiation, and early age at first menstruation, having children late or not at all, older age, and family history. About 5-10% of cases are due to genes inherited from a person's parents, including BRCA1 and BRCA2 among others. Breast cancer most commonly develops in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas while those developing from lobules are known as lobular carcinomas. In addition, there are more than 18 other sub-types of breast cancer. Some cancers develop from pre-invasive lesions such as ductal carcinoma in situ. The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning lump.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Pediatric cancer

Childhood cancer (also known as pediatric cancer) is cancer in a child. In the United States, an arbitrarily adopted standard of the ages used are 0-14 years inclusive, that is, up to 14 years 11.9 months of age. However, the definition of childhood cancer sometimes includes young adults between 15-19 years old. Pediatric oncology is the branch of medicine concerned with the diagnosis and treatment of cancer in children. Worldwide, it is estimated that childhood cancer has an incidence of more than 175,000 per year, and a mortality rate of approximately 96,000 per year. In developed countries, childhood cancer has a mortality of approximately 20% of cases. In low-resource settings, on the other hand, mortality is approximately 80% or even 90% in the world's poorest countries. In many developed countries the incidence is slowly increasing, as rates of childhood cancer increased by 0.6% per year between 1975 to 2002 in the United States and by 1.1% per year between 1978 and 1997 in Europe.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Prostate cancer

Vector- borne diseases, most of which are transmitted in and around the home, are best controlled by a combination of vector control (use of public health insecticides on bednets, or by spraying), medicines and vaccines. In contrast to expenditure and effort on medicine, diagnostic and vaccine development, relatively little attention was given to vector control in the past. The foresighted establishment of IVCC in 2005, with a grant from the Bill and Melinda Gates Foundation, began the process of bringing Vector Control into the mainstream strategy for future eradication of malaria and other vector-borne diseases. Although WHO emphasizes that new strategies for prevention and control of vector-borne diseases should be through "integrated vector management", most technologies are at least 25 years old.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Vaccine Research and Development

Prostate cancer, also known as carcinoma of the prostate, is the development of cancer in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, some grow relatively quickly. The cancer cells may spread from the prostate to other parts of the body, particularly the bones and lymph nodes. It may initially cause no symptoms. In later stages, it can lead to difficulty urinating, blood in the urine, or pain in the pelvis, back or when urinating. A disease known as benign prostatic hyperplasia may produce similar symptoms. Other late symptoms may include feeling tired due to low levels of red blood cells. Prostate cancer is diagnosed by biopsy. Medical imaging may then be done to determine if cancer has spread to other parts of the body. Prostate cancer was the most common cancer in males in 84 countries, occurring more commonly in the developed world. Rates have been increasing in the developing world. Detection increased significantly in the 1980s and 1990s in many areas due to increased PSA testing. Studies of males who died from unrelated causes have found prostate cancer in 30% to 70% of those over age 60.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Cancer identification using Radiology and Imaging technologies

Radiology is a medical specialty that uses imaging to diagnose and treat diseases seen within the body. Radiologists use a variety of imaging techniques such as X-ray radiography, ultrasound, computed tomography (CT), nuclear medicine including positron emission tomography (PET), and magnetic resonance imaging (MRI) to diagnose and/or treat diseases. Interventional radiology is the performance of (usually minimally invasive) medical procedures with the guidance of imaging technologies. These digital infrared imaging thermographic techniques are based on the principle that metabolic activity and vascular circulation in both pre-cancerous tissue and the area surrounding a developing breast cancer is almost always higher than in normal breast tissue. Cancerous tumors require an ever-increasing supply of nutrients and therefore increase circulation to their cells by holding open existing blood vessels, opening dormant vessels, and creating new ones (neo-angiogenesis theory).

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Radiation-induced cancer

Diagnostic medical radiation has been the most rapidly increasing component of population background radiation exposure in Western countries over the past decade.Up to 10% of invasive cancers are related to radiation exposure, including both ionizing radiation and non-ionizing radiation. Additionally, the vast majority of non-invasive cancers are non-melanoma skin cancers caused by non-ionizing ultraviolet radiation. Ultraviolet's position on the electromagnetic spectrum is on the boundary between ionizing and non-ionizing radiation. Non-ionizing radio frequency radiation from mobile phones, electric power transmission, and other similar sources have been described as a possible carcinogen by the World Health Organization's International Agency for Research on Cancer, but the link remains unproven. Exposure to ionizing radiation is known to increase the future incidence of cancer, particularly leukemia. The mechanism by which this occurs is well understood, but quantitative models predicting the level of risk remain controversial. The most widely accepted model posits that the incidence of cancers due to ionizing radiation increases linearly with effective radiation dose at a rate of 5.5% per sievert. If the linear model is correct, then natural background radiation is the most hazardous source of radiation to general public health, followed by medical imaging as a close second.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Adjuvant radiation therapy for cancer

Adjuvant therapy or care, also called adjunct therapy or adjunctive therapy or care, is a therapy that is given in addition to the primary, main, or initial therapy to maximize its effectiveness. For example, radiotherapy or systemic therapy is commonly given as adjuvant treatment after surgery for breast cancer. Systemic therapy consists of chemotherapy, immunotherapy or biological response modifiers or hormone therapy. Oncologists use statistical evidence to assess the risk of disease relapse before deciding on the specific adjuvant therapy. The aim of adjuvant treatment is to improve disease-specific symptoms and overall survival. Because the treatment is essentially of a risk, rather than for provable disease, it is accepted that a proportion of patients who receive adjuvant therapy will already have been cured by their primary surgery. Adjuvant systemic therapy and radiotherapy are often given following surgery for many types of cancer, including colon cancer, lung cancer, pancreatic cancer, breast cancer, prostate cancer, and some gynecological cancers. Some forms of cancer fail to benefit from adjuvant therapy, however. Such cancers include renal cell carcinoma and certain forms of brain cancer.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

PET/MRI versus PET/CT Hybrid

Positron emission tomography (PET) scanning deals with positrons instead of gamma rays detected by gamma cameras. The positrons annihilate to produce two opposite traveling gamma rays to be detected coincidentally, thus improving resolution. In PET scanning, a radioactive, biologically active substance, most often 18F-FDG, is injected into a patient and the radiation emitted by the patient is detected to produce multiplanar images of the body. Metabolically more active tissues, such as cancer, concentrate the active substance more than normal tissues. PET images can be combined (or "fused") with anatomic (CT) imaging, to more accurately localize PET findings and thereby improve diagnostic accuracy. The fusion technology has gone further to combine PET and MRI similar to PET and CT. PET/MRI fusion, largely practiced in academic and research settings could potentially play a crucial role in the fine detail of brain imaging, breast cancer screening, and small joint imaging of the foot. The technology recently blossomed after passing the technical hurdle of altered positron movement in the strong magnetic field thus affecting the resolution of PET images and attenuation correction.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Medical Imaging for cancer

Medical imaging is the technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues (physiology). Medical imaging seeks to reveal internal structures hidden by the skin and bones, as well as to diagnose and treat disease. Medical imaging also establishes a database of normal anatomy and physiology to make it possible to identify abnormalities. Although imaging of removed organs and tissues can be performed for medical reasons, such procedures are usually considered part of pathology instead of medical imaging. Cancer may be difficult to detect, but for some types of cancer, the earlier it is detected, the better are the chances of treating it effectively. Imaging techniques - methods of producing pictures of the body - have become an important element of early detection for many cancers. But imaging is not simply used for detection. Imaging is also important for determining the stage (telling how advanced the cancer is) and the precise locations of cancer to aid in directing surgery and other cancer treatments, or to check if cancer has returned.

Recommended: cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016nursing conferences dubai UAE, october 27-29 2016.

Other Magnus Group conferences:
Cancer conferences
dubai : cancer conferences, cancer conference, cancer congress, cancer workshops, cancer symposiums, oncology conferences, oncology conference, oncology congress, oncology workshops, oncology symposiums, radiology conferences, radiology conference, radiology workshops, radiology symposiums, icor, icor 2016
Rare diseases conferences
dubai : rare diseases conferences, rare diseases congress, rare diseases conference, orphan diseases conferences, orphan diseases conference, orphan drugs conferences, orphan drug conference, grod, grod 2016, rare diseases symposiums, rare diseases workshops
Petrochemistry conferences
dubai: petrochemistry conferences, petrochemistry conference, petroleum conferences, petroleum conference, Oil Conferences, Gas Conferences, petroleum engineering Conferences, chemical engineering conferences, chemical engineering conference, ipcc, ipcc 2016, petrochemistry workshops, petrochemistry symposiums, petochemistry congress, chemical engineering workshops, petrochemistry congress, chemical engineering symposiums
Neurology conferences
dubai : Neurology Conferences, Neuroscience Conferences, Brain disorders Conferences, Neurology Congresses, Neuroscience Congresses, Brain disorders Conferences, INBC 2016, INBC, Neurology Events, Neuroscience Events, Brain disorders Events, Neurology Conferences 2016, Neuroscience Conferences 2016, Brain disorders Conferences 2016, Neurology Congresses 2016, Brain disorders Congresses 2016 , Neurology Events 2016, Neuroscience Events 2016, Neurology Conference, Neuroscience Conference, Neurology Congress, Neurology Conference USA (America), Neurology Conference Europe, Neurology Conference Middle east, Neuroscience Conference USA (America), Neuroscience Conference Europe, Neuroscience Conference Middle east, Brain disorders Conference USA (America),
 

"Go back to the work with proven techniques to make it easier in your company to share information, automate business process and be more protective than ever"

Committee Members


In Collaboration with

img img

Exhibitor

img

Target Audience


  • Public Health Professionals
  • Drug Manufacturing Companies
  • Medical Oncologist
  • Radiation Therapist
  • Oncology Societies
  • Clinical Research
  • Leading world Doctors
  • Surgical Oncologist

Venue & Hospitality

Contact Us